细胞因子佐剂研究进展

doi:10.16431/j.cnki.1671-7236.2017.01.042

Abstract

Abstract:

As an adjuvant, cytokine plays a key role in regulating the innate and adaptive immunity and enhancing the vaccine specific immune responses. The researches on the interleukin, interferon, granulocyte macrophage colony stimulating factors, tumor necrosis factors, and chemotactic factor have made considerable progress. Now we reviewed the cytokine adjuvant application in order to provide reference for the future application.

Key words: cytokine; adjuvant; interferon; interleukin

CLC Number:

S852.4

LI Shi-fang, LIU Ze-zhong, CHANG Hui-yun. Research Progress on Cytokine Adjuvants[J]. , 2017, 44(1): 296-301.

References

[1] 郑世军.动物分子免疫[M].北京:中国农业出版社,2015.
[2] Villarreal D O, Siefert R J, Weiner D B. Alarmin IL-33 elicits potent TB-specific cell-mediated responses[J]. Human Vaccines & Immunotherapeutics,2015, 11(8):1954-1960.
[3] Hu X, Cao Y, Meng Y, et al. A novel modulation of structural and functional changes of mouse bone marrow derived dendritic cells (BMDCs) by interleukin-2(IL-2)[J]. Human Vaccines & Immunotherapeutics, 2015, 11(2):516-521.
[4] Kim N, Jeon Y W, Nam Y S, et al. Therapeutic potential of low-dose IL-2 in a chronic GVHD patient by in vivo expansion of regulatory T cells[J]. Cytokine, 2016, 78:22-26.
[5] Zhang C, Wang B, Wang M. GM-CSF and IL-2 as adjuvant enhance the immune effect of protein vaccine against foot- and-mouth disease[J]. Virology Journal, 2011, 8:7.
[6] Parhar R S, Zou M, Al-Mohanna F A, et al. IL-12 immunotherapy of Braf (V600E)-induced papillary thyroid cancer in a mouse model[J]. Laboratory Investigation, 2016, 96(1):89-97.
[7] Jalah R, Patel V, Kulkarni V, et al. IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques[J]. Human Vaccines & Immunotherapeutics, 2012, 8(11):1620-1629.
[8] Naderi M, Saeedi A, Moradi A, et al. Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity[J]. Virologica Sinica, 2013, 28(3):167-173.
[9] Croci S, Nanni P, Palladini A, et al. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis[J]. Breast Cancer Research, 2015, 17:70.
[10] Cha E, Graham L, Manjili M H, et al. IL-7+IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo[J]. Breast Cancer Research and Treatment, 2010, 122(2):359-369.
[11] Huang P L, Hou M S, Wang S W, et al. Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis[J]. Skeletal Muscle, 2015, 5:33.
[12] Dai S, Zhou X, Wang B, et al. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(⁺) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells[J]. J Mol Med (Berl), 2006, 84(12):1067-1076.
[13] Lim K L, Jazayeri S D, Yeap S K, et al. Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses[J].Bmc Veterinary Research, 2012, 8:132.
[14] Lian H, Jin N, Li X, et al. Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and apoptin[J]. Cancer Immunology Immunotherapy, 2007, 56(2):181-192.
[15] Hu K, He X, Yu F, et al. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis[J]. Immunological Investigations, 2011, 40(3):265-278.
[16] He X, Wang J, Zhao F, et al. Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatousmouse[J]. Immunologic Research, 2012, 52(3):240-249.
[17] Wu B, Zou Q, Hu Y, et al. Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8(+) T cell responses against a HBV DNA vaccine in mice[J]. Human Vaccines & Immunotherapeutics, 2013, 9(10):2133-2141.
[18] Hong S, Qian J, Li H, et al. CpG or IFN-alpha are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma[J]. Cancer Immunology Immunotherapy, 2012, 61(4):561-571.
[19] Cheng Z P, Cheng A C, Wang M S, et al. Effect of cell mediated immunity regulation of duck enhanced by duck IFN-γ eukaryon expression plasmid and inoculated with DPV attenuated vaccine by gene-gun[J]. Frontiers of Agriculture in China, 2008, 2(3):343-347.
[20] Davies G, Vaccine Adjuvants:Methods and Protocols[M].New York:Humana Press, 2010.
[21] Bandera A, Trabattoni D, Ferrario G, et al. Interferon-gamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis[J]. Infection, 2008, 36(4):368-373.
[22] Milanés-Virelles M T, García-García I, Santos-Herrera Y, et al. Adjuvant interferon gamma in patients with pulmonary atypical mycobacteriosis:A randomized, double-blind, placebo-controlled study[J]. Bmc Infectious Diseases, 2008, 8:17.
[23] Morrow M P, Yan J, Pankhong P, et al. IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques[J]. Molecular Therapy, 2010, 18(9):1714-1723.
[24] Wen Q, Xiong W, He J, et al. Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions[J]. Journal of Translational Medicine, 2016, 14:41.
[25] Noh K H, Park Y M, Kim H S, et al. GM-CSF-loaded chitosan hydrogel as an immunoadjuvant enhances antigen-specific immune responses with reduced toxicity[J]. Bmc Immunology, 2014, 15:48.
[26] Zhang H, Qian P, Peng B, et al. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets[J]. Vaccine, 2015, 33(21):2449-2456.
[27] Seo S H, Han H D, Noh K H, et al. Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8(⁺) T cell-mediated anti-tumor immunity[J]. Clinical & Experimental Metastasis, 2009, 26(3):179-187.
[28] Mittendorf E A, Holmes J P, Ponniah S, et al. The E75 HER2/neu peptide vaccine[J]. Cancer Immunology Immunotherapy, 2008, 57(10):1511-1521.
[29] Wen J, Hao W, Fan Y, et al. Co-delivery of LIGHT expression plasmid enhances humoral and cellular immune responses to HIV-1 Nef in mice[J]. Archives of Virology, 2014, 159(7):1663-1669.
[30] Liu H Z, Song R, Zhang J X,et al. Molecular cloning, recombinant expression, and funtional characterization of APRIL (TNFSF13) in cat (Felis catus)[J]. Anmial Biotechnology, 2016, 27(1):1-8.
[31] Kathuria N, Kraynyak K A, Carnathan D, et al. Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant[J]. Human Vaccines & Immunotherapeutics, 2012, 8(11):1607-1619.
[32] Liu Z Q, Ravindranathan R, Li J, et al. CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy[J]. Onco Immunology, 2015, 5(3):e1091554.
[33] Hartoonian C, Sepehrizadeh Z, Mahdavi M, et al. Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20(CCL20) gene as immunoadjuvant[J]. Molecular Biology Reports, 2014, 41(9):5943-5952.
[34] Kutzler M A, Kraynyak K A, Nagle S J, et al. Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo[J]. Gene Therapy, 2010, 17(1):72-82.

Research Progress on Cytokine Adjuvants

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	HAN Bing, TANG Siqi, ZHU Dawei, LI Hailing, FENG Yali, SU Chaofan, XU Yina, LENG Haoyu, WANG Yongtao, ZHANG Yuemei, TAI Xiaochun, ZHANG Ying. Research Progress of Novel Vaccine Adjuvants [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(6): 2460-2467.
[2]	SHAO Yongbin, ZHENG Yichuang, ZHANG Jingyi, WEI Linying, TIAN Yong, SUN Guojie, LIU Yuran, LUO Yan, GU Xinli. Study on the Anti-inflammatory Effect of Leonurine on LPS-induced Endometritis in Mice [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(5): 2149-2155.
[3]	LIU Xinyue, LI Lifang, WANG Zhenbao, ZHANG Wenliang, ZHANG Xin, ZHAO Hongtao, LI Pengyu, ZHENG Haotian, XIAO Jin, QI Peng. Adjuvants Screening and Immune Protection of Porcine Circovirus Type 2 Synthetic Peptide Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(3): 1068-1080.
[4]	LIU Haoyuan, LI Yanjie, QIN Hewei, JIN Xiaoqin, NIU Yuqing, HUA Xiaoqiong, ZHANG Shuqin, NIU Li. Study on the Mechanism of WU Shen Venation Smooth Decoction on Atherosclerosis AopE^-/- Mice Based on Network Pharmacology [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(1): 377-389.
[5]	LIU Hongying, WANG Jingyu, CUI Zhenzhen, MA Qingxia, WANG Tingting, LI Jianming, SHI Kun, GONG Qinglong, DU Rui, LENG Xue. Research Progress on Immune Adjuvant Effect and Related Mechanism of Active Ingredients of Traditional Chinese Medicine on Animal Vaccines [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(1): 390-397.
[6]	SONG Shiying, GUO Weilu, XIA Xuefeng, ZHANG Xue, BI Zhenwei, ZHANG Xuehan, FAN Baochao, DONG Hailong, LI Bin. Expression and Purification of Porcine IFN-δ5 and Its Effect Analysis Against PEDV Infection [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(8): 3171-3179.
[7]	LIU Yuran, YANG Huiying, ZHU Yan, WANG Mengmeng, SUN Guojie, ZHANG Mengyuan, WANG Yan, GAO Jiahao, LIAN Kexun, GU Xinli. Study on the Anti-inflammatory Effect of ‘Ruyan Ning’ Water Extract [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(5): 1879-1887.
[8]	SHI Qian, XU Xinfeng, LI Xuewen, XIAO Yuanyuan, BAI Meihua, ZHANG Fuchun. Research Progress on the Mechanism of Polysaccharide as Adjuvant of Veterinary Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(5): 1895-1907.
[9]	CHEN Yu, CHEN Xiaolan, YANG Haifeng, LUO Jun, ZHANG Ting, ZUO Haiping, ZHENG Yi. Therapeutic Effect of Wuwei Zhili Mixture on Diarrhea Induced by Escherichia coli in Mice [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(5): 2001-2009.
[10]	ZHANG Jinghan, LI Zhilan, HAN Diangang, HE Shuai, LIU Jinhua, LYU Nianci, ZOU Fengcai, CHAI Jun, ZHANG Yifang. Construction of PK-15 Cells Stably Expressing IL-10 and Its Application in PCV2 Proliferation [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(3): 1085-1095.
[11]	QIU Shulei, CHEN Xiaolan, YANG Haifeng, CHEN Yuku, HU Yuanliang, GAO Yongxu, WU Caihong. Effects of Selenized Garlic Polysaccharide on the Function of Mouse Peritoneal Macrophages [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(3): 1144-1152.
[12]	YIN Huihui, TONG Yanmei, ZENG Xueyan, LU Guangqiang, ZHAO Wu, JIANG Yuanming, LIU Wei. Effect of Polysaccharide from Rhodomyrtus tomentosa Fruit on Immunological Function in Immunosuppressed Mice [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(2): 731-737.
[13]	ZHAO Yi, ZHANG Wen, CHEN Jiaji, SONG Manling, CHEN Qi, XIE Xiaodong, HU Tingjun. Establishment of 3D4/2 Cell Inflammatory Model Induced by PCV2 in vitro [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(12): 4920-4927.
[14]	ZHAO Weijie, SUN Yaogui, SUN Panpan, SUN Na, YANG Huizhen, LI Hongquan. Study on Repair Effect and Mechanism of Nigella sativa Seed Extract on Alcoholic Liver Injury in Mice [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(12): 4928-4935.
[15]	SHAN Chunlan, ZHANG Bo, ZHAO Weiwei, WANG Hao, YANG Wei, DENG Jing, ZHAO Ru, GAO Libo, XIAO Peng, LYU Longbao, GAO Hong. Ultrastructural Characteristics of Pathological Damage Induced by Escherichia coli High Pathogenicity Island from Saba Pig [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(9): 3491-3499.